Related Experiment Videos

Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins

Neurology
|September 1, 1987
PubMed

Insights

Peripheral neuropathy affects nearly half of macroglobulinemia patients, sometimes without symptoms. This study explores the link between M proteins, anti-myelin-associated glycoprotein (MAG) activity, and nerve damage in these patients.

Area of Science:

  • Neurology
  • Immunology
  • Hematology

Background:

  • Macroglobulinemia is a rare B-cell cancer.
  • Peripheral neuropathy is a known complication of macroglobulinemia.

Purpose of the Study:

  • To investigate the prevalence and characteristics of peripheral neuropathy in macroglobulinemia patients.
  • To explore the role of anti-myelin-associated glycoprotein (MAG) activity and M protein binding in the pathogenesis of neuropathy.

Main Methods:

  • Patient cohort assessment (n=26) for peripheral neuropathy.
  • Measurement of anti-MAG antibody activity.
  • Sural nerve biopsies for histopathology and immunofluorescence.
  • Immunoblotting and immunofluorescence assays for M protein binding to nerve components.

Main Results:

  • Peripheral neuropathy observed in 46% of patients, with 2 cases being subclinical.
  • Anti-MAG activity detected in 50% of neuropathic patients.
  • Nerve biopsies revealed demyelination and IgM deposits; M protein binding to myelin was confirmed in one patient without anti-MAG activity.

Conclusions:

  • Peripheral neuropathy is common in macroglobulinemia.
  • The pathogenesis may involve anti-MAG antibodies or direct M protein binding to peripheral nerve antigens.
  • Antigen-specificity of M proteins may be crucial in developing neuropathy.

Related Concept Videos